| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Department of Veterans Affairs, VA Medical Center; and 2 University of Minnesota Cancer Center, Minneapolis, Minnesota
Requests for reprints: Anne Joseph, Section of General Internal Medicine (111-0), VA Medical Center, One Veterans Drive, Minneapolis, MN 55417. Phone: 612-725-2158; Fax: 612-725-2118. E-mail: Anne.M.Joseph{at}med.va.gov
Epidemiologic studies show a dose-response relationship between cigarettes per day and health outcomes such as heart and lung disease, and health outcomes are related to some biomarkers of tobacco exposure. The objective of this study was to examine the relationships between cigarettes per day and levels of selected biomarkers of tobacco toxin exposure: carbon monoxide (CO), metabolites of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and polycyclic aromatic hydrocarbons [total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and 1-hydroxypyrene (1-HOP), respectively], and total cotinine (cotinine plus cotinine-N-glucuronide). We did a cross-sectional analysis of merged data from (a) two clinical trials and (b) two cohorts of light smokers (total n = 400). The mean age of participants was 50.4 years and the range of cigarette consumption was 1 to 100/d; however, few subjects smoked >45 cigarettes/d (n = 12). Results show that levels of the biomarkers CO, total NNAL, and total cotinine increase with an increase in the number of cigarettes smoked per day, but not in a linear fashion. 1-HOP is a less discriminating biomarker as levels are relatively stable regardless of the number of cigarettes smoked per day. There is considerable variability in toxin measurement, especially at high levels of smoking. There was a significant correlation between cigarettes per day and total NNAL, 1-HOP, total cotinine, and CO. Total NNAL was highly significantly correlated with total cotinine and CO and also significantly correlated with 1-HOP. These findings suggest that the number of cigarettes smoked per day is not necessarily a reliable measure of toxin exposure and may underestimate tobacco toxin exposure at low levels of smoking or overestimate exposure at high levels of smoking. (Cancer Epidemiol Biomarkers Prev 2005;14(12):2963-8)
This article has been cited by other articles:
|
|
 |
|
  J.-M. Yuan, W.-P. Koh, S. E. Murphy, Y. Fan, R. Wang, S. G. Carmella, S. Han, K. Wickham, Y.-T. Gao, M. C. Yu, et al. Urinary Levels of Tobacco-Specific Nitrosamine Metabolites in Relation to Lung Cancer Development in Two Prospective Cohorts of Cigarette Smokers Cancer Res., April 1, 2009; 69(7): 2990 - 2995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Hertsgaard, K. Hanson, S. S. Hecht, B. R. Lindgren, X. Luo, S. G. Carmella, W. T. Riley, E. B. Zylla, S. E. Murphy, and D. K. Hatsukami Exposure to a Tobacco-Specific Lung Carcinogen in Adolescent versus Adult Smokers Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3337 - 3343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W. Rees, G. F. Wayne, and G. N. Connolly Puffing Style and Human Exposure Minimally Altered by Switching to a Carbon-Filtered Cigarette Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 2995 - 3003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Stepanov, P. Upadhyaya, S. G. Carmella, R. Feuer, J. Jensen, D. K. Hatsukami, and S. S. Hecht Extensive Metabolic Activation of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Smokers Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1764 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. G. Carmella, I. Stepanov, J. Jensen, A. Anderson, and D. K. Hatsukami Metabolism of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone to Its Biomarker Total NNAL in Smokeless Tobacco Users Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 732 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Lubin, N. Caporaso, D. K. Hatsukami, A. M. Joseph, and S. S. Hecht The Association of a Tobacco-Specific Biomarker and Cigarette Consumption and Its Dependence on Host Characteristics Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1852 - 1857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Stepanov, S. S. Hecht, B. Lindgren, P. Jacob III, M. Wilson, and N. L. Benowitz Relationship of Human Toenail Nicotine, Cotinine, and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol to Levels of These Biomarkers in Plasma and Urine Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1382 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Hatsukami, C. T. Le, Y. Zhang, A. M. Joseph, M. E. Mooney, S. G. Carmella, and S. S. Hecht Toxicant Exposure in Cigarette Reducers versus Light Smokers Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2355 - 2358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. G. Carmella, A. Yoder, M. Chen, Z.-z. Li, C. Le, R. Dayton, J. Jensen, and D. K. Hatsukami Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1805 - 1811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Carmella, A. Yoder, and S. S. Hecht Combined Analysis of r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-Tetrahydrophenanthrene and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol in Smokers' Plasma. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1490 - 1494. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
